Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced the availability of a new solution that enables seamless access to Infraredx’s true vessel characterization (TVC) Imaging System via Philips’ Allura Xper catheterization (cath) lab imaging systems. The product offering ensures compatibility between the two systems and allows clinicians to quickly and easily connect the TVC Imaging System to the Allura Xper system when intravascular imaging is required as part of cardiac catheterization procedures.
The new solution is the result of a joint product development agreement announced by Infraredx and Philips in October 2012 that aims to improve the integrated functioning of the cath lab with the TVC Imaging System’s near-infrared spectroscopy (NIRS) and intravascular ultrasound (IVUS) technologies. The software application will be demonstrated at the upcoming American College of Cardiology (ACC) 2013 annual meeting at the Philips booth (#S1009).
With the new solution, clinicians can now operate the TVC Imaging System at the X-ray table and view the TVC Composite Image, which shows both NIRS and IVUS images, alongside the coronary angiogram on the Philips cath lab monitors. This allows for better visualization of lipid core-containing plaques (LCPs) in a patient’s coronary arteries. LCP is believed to be "vulnerable plaque" that can rupture and form dangerous blood clots leading to coronary heart attacks, and is widely considered to be responsible for a significant number of stenting procedure complications.
“We are pleased to introduce this new integrated solution for the interventional cardiology community, which enables tableside control of the TVC Imaging System from within the sterile cath lab environment using the Allura Xper system,” said Don Southard, president and chief executive officer of Infraredx. “By providing clinicians with more control over the procedure and accelerated information retrieval, this solution will improve our customers’ clinical workflow and productivity. We look forward to continuing to partner with Philips to develop additional integrated intravascular imaging solutions for customers who desire optimal percutaneous coronary intervention results.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts